Arvinas (ARVN) EPS (Basic) (QoQ) (2017 - 2026)
Arvinas (ARVN) EPS (Basic) (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Arvinas | 531.20 Mn | -83.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.33% |
| Dec 31, 2025 | -98.25% |
| Sep 30, 2025 | 42.80% |
| Jun 30, 2025 | -173.32% |
| Mar 31, 2025 | 282.29% |
| Dec 31, 2024 | 8.08% |
| Sep 30, 2024 | -39.39% |
| Jun 30, 2024 | 49.42% |
| Mar 31, 2024 | 65.30% |
| Dec 31, 2023 | -136.14% |
| Sep 30, 2023 | 3.41% |
| Jun 30, 2023 | 19.33% |
| Mar 31, 2023 | -0.68% |
| Dec 31, 2022 | -26.54% |
| Sep 30, 2022 | 6.22% |
| Jun 30, 2022 | -10.06% |
| Mar 31, 2022 | -25.04% |
| Dec 31, 2021 | 1.87% |
| Sep 30, 2021 | 8.73% |
| Jun 30, 2021 | -22.08% |